Business Today

Cipla recalls 4,800 bottles of anti-HIV tablets from American market

Cipla is recalling 4,800 bottles of Nevirapine extended-release tablets used for the treatment of HIV from the American market

twitter-logo PTI        Last Updated: December 30, 2018  | 13:44 IST
Cipla recalls 4,800 bottles of anti-HIV tablets from American market

Drug major Cipla is recalling 4,800 bottles of Nevirapine extended-release tablets used for the treatment of human immunodeficiency virus (HIV) from the American market, according to a report by the US health regulator.

As per the latest Enforcement Report by the United States Food and Drug Administration (USFDA), the reason for the recall of the bottles is 'failed dissolution specifications'.

Also Read: At 2.6 degrees Celsius, Delhi records coldest December day in five years

Nevirapine extended-release tablets, 400 mg in the 30-count bottle have been manufactured by Cipla at its Goa facility for Cipla USA Inc, it added.

The US health regulator has not yet classified the voluntary recall by the company, the report said.

Also Read: KGF box office collection Day 9: Yash's film inching towards Rs 150-crore mark, despite Simmba challenge

Also Read: Simmba Box Office Collection Day 2: Ranveer Singh-Sara Ali Khan's movie is off to a great start

Youtube
  • Print

  • COMMENT
BT-Story-Page-B.gif
A    A   A
close